Investigating a Correlation between Chemoradiotherapy Schedule Parameters and Overall Survival in a real-life LD SCLC Patient Cohort.

J Cancer · 2016 · PMC5118664 · PMID 27877216

Europe PMC DOI

hedged sentence

0.1090

closest p · 2.2× alpha

0.1090

boldest claim

The sentences

showed a trendp=0.109not close (p > 0.1)

Evaluation of the entire cohort demonstrated that patients treated with IST > 0 and < 35 days showed a trend to improved overall survival (IST 0 vs. > 35 vs. < 35 was 533: 95%CI 446 - 620 vs. 448: 95%CI 361 - 535 vs. 1169: 95%CI 800 - 1538 days, p=0.109, log-rank test) (See Figure 3 and Table 2 ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.